3DMED Biomedical
Founded Year
2015Stage
IPO | IPOTotal Raised
$144.88MDate of IPO
12/15/2022About 3DMED Biomedical
3DMED Biomedical, spun off from 3DMED, is a biomedical company engaged in the development and commercialization of a new generation of tumor immunotherapy drugs. The company was founded in 2015 and is based in Shanghai, China.
Missing: 3DMED Biomedical's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: 3DMED Biomedical's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing 3DMED Biomedical
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
3DMED Biomedical is included in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
3DMED Biomedical Frequently Asked Questions (FAQ)
When was 3DMED Biomedical founded?
3DMED Biomedical was founded in 2015.
Where is 3DMED Biomedical's headquarters?
3DMED Biomedical's headquarters is located at Building 11, No.118 Furonghua Road, Shanghai.
What is 3DMED Biomedical's latest funding round?
3DMED Biomedical's latest funding round is IPO.
How much did 3DMED Biomedical raise?
3DMED Biomedical raised a total of $144.88M.
Who are the investors of 3DMED Biomedical?
Investors of 3DMED Biomedical include Ruixia Investment, Tigermed, EFung Capital, Adrian Cheng, China Capital Management and 5 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.